17th International Congress on Infectious Diseases
Hyderabad International Convention Centre (HICC) *Hyderabad, INDIA Visit the Venue to read more
Dear Members, Colleagues, Sponsors and friends:
I am delighted to announce that the International Society for Infectious Diseases will hold our next International Congress on Infectious Diseases (ICID) in Hyderabad, India, from the 2nd to the 5th March 2016. The ISID has always had a particular focus on the global burden of infectious diseases and I am therefore particularly pleased that the meeting will be held in India, the fi rst time that we have visited that country and a real opportunity for us to get to know the many colleagues who work there and in other parts of the region. The meeting will encompass all of the fi elds of infectious diseases with particular attention being paid to the major challenges of the region including AIDS, malaria, tuberculosis, pneumonia and enteric infections including typhoid fever and diarrhea. In addition, major areas of neglected tropical diseases will be discussed and there will be a particular focus on disease prevention and vaccination.
One of the things that distinguishes ISID meetings is the unique blend of state-of-the-art scientifi c presentations that encompass both basic science and clinical practice, delivered by a truly international faculty who uniquely have the handson experience and knowledge of the conditions that they discuss. Our meetings are also notable for their representation from an extraordinarily wide range of countries, and the opportunity for close exchange and communication between the most senior and more junior colleagues.
ISID is a truly global society with over 60,000 members worldwide, and a vibrant range of activities that includes ProMED, our biennial meeting on Emerging Infectious Diseases (IMED), a prestigious Fellowship program, the International Journal of Infectious Diseases and much more. We are greatly looking forward to collaborating with our colleagues in India and we hope you will be able to join us for what will be an outstanding meeting.
I look forward to seeing you there.
President, International Society for Infectious Diseases
'Toward a Genetic Theory of Childhood Infectious Diseases'
Dr. Casanova is a Professor and Head of Laboratory at the Rockefeller University, Senior Attending Physician at the Rockefeller University Hospital, and an Investigator of the Howard Hughes Medical Institute. A pediatrician and immunologist by training, now works as a geneticist investigating infectious diseases. He discovered that life-threatening infectious diseases of childhood may be caused by single-gene inborn errors of immunity. He revealed single-gene mutations that create ‘holes’ in the immune system of children who are susceptible to specific infectious diseases, yet remain normally resistant to other infectious agents. Until these discoveries, single-gene lesions were only thought to underlie rare Mendelian traits, predisposing affected children to multiple infectious diseases.
Dr. Casanova was an international research scholar with the Howard Hughes Medical Institute from 2005 to 2008 and was elected to the European Molecular Biology Organization in 2005. He received the Professor Lucien Dautrebande Pathophysiology Foundation Prize in 2004, the Richard Lounsbery Award in 2008, the Oswald Avery Award from the Infectious Disease Society of America in 2009, the E. Mead Johnson Award from the Society for Pediatric Research in 2010, the InBev Baillet-Latour Health Prize in 2011, the Ilse and Helmut Wachter Foundation Award and the Milstein Award in 2012. In 2014, he was given the American Pediatric Society Norman J. Siegel New Member Outstanding Science Award, the Presidential Award of the Clinical Immunology Society, the Robert Koch Prize, and the Sanofi-Institute Pasteur Award.
SALLY C. DAVIES
'Antimicrobial Resistance: From Problem to Policy to Action'
Professor Dame Sally Davies is England’s Chief Medical Officer (CMO), and the Chief Scientific Adviser for the Department of Health. As CMO she is the independent advisor to the Government on all medical matters, particularly Public Health. The CMO also advises the Health Secretary on medical matters and promoting the health and well being of the people of England. She carries the rank of Permanent Secretary and is the professional head of the Department’s medical staff and head of the Medical Civil Service. Prof. Davies has been actively involved in NHS R&D from its establishment. As Director-General she established the National Institute for Health Research (NIHR) with a budget of £1 billion. Her own research interests focused on Sickle Cell disease.
Long an active participant in WHO, Prof. Davies led the UK delegation to the Ministerial Summit in November 2004 and the Forum on Health Research in November 2008. She spoke on R&D at the World Health Assembly in May 2005 and serves the WHO Global Advisory Committee on Health Research. She also chaired the Expert Advisory Committee for the development of the WHO research strategy. She is a member of the International Advisory Committee for A*STAR, Singapore and has advised many other organizations on research strategy and evaluation.
Prof. Davies was awarded a DBE (Dame Commander of the British Empire) in the New Year Honours 2009 for services to medicine. In September 2011 she was conferred as Emeritus Professor at Imperial College London.
'Challenges and Opportunities in the Management of Chronic Hepatitis B Infection'
Ching-Lung Lai is the Simon K Y Lee Professor in Gastroenterology and the Chair Professor of Medicine and Hepatology at the Department of Medicine, University of Hong Kong, where he has been working since his graduation.
For the last three decades he has been extensively involved in research into various aspects of HBV, including hepatocellular carcinoma. He is one of the lead investigators in the pivotal trials of various nucleos(t)ide analogues which have revolutionised the treatment of chronic hepatitis B. He and his colleagues have also been investigating the still emerging field of the natural history of chronic hepatitis B, with findings which have an important bearing on the treatment end-points for chronic hepatitis B.
Professor Lai has published over 450 peer-reviewed papers and reviews in international journals. His publications have been widely cited and he is one of top scientists in the field of chronic hepatitis B infection. He has also been awarded multiple awards by the University of Hong Kong for his outstanding teaching.
'Tuberculosis: Challenges and Solutions in the 21st Century'
Dr. Swaminathan is a pediatrician by training, having completed her medical education at the Armed Forces Medical College and the All India Institute of Medical Sciences followed by a fellowship in pediatric pulmonology at the Children’s Hospital of Los Angeles. She has spent over 24 years at the Tuberculosis Research Centre in Chennai, (now renamed the National Institute for Research in Tuberculosis), where she is currently the Director.
She has over 200 peer-reviewed publications and serves on many national and international committees. Her major research interests are in pediatric and adult TB, their interaction with HIV and nutrition and the management of co-infections as well as pharmacokinetics and pharmacogenetics.
She is an elected Fellow of three of India’s Science Academies and chaired the HIV section of the International Union against TB and Lung Diseases 2011–2013. She also served as Coordinator for Neglected Priorities Research at WHO/TDR, Geneva 2009–2011. She is the recipient of several awards for excellence in biomedical sciences.
PAUL ANANTHARAJAH TAMBYAH
'MERS, Ebola, SARS and H1N1: Local and Global Responses to Viral Threats'
Paul Anantharajah Tambyah is currently Professor of Medicine at the National University of Singapore and Senior Consultant Infectious Diseases Physician at the National University Hospital. He is also Research Director in the Division of Infectious Diseases of the National University Health System. After graduating from the National University of Singapore, he did his postgraduate training at the University of Wisconsin under Dr Dennis Maki and since returning to Singapore in 1999 he has held a number of academic, professional and advisory appointments including Assistant Dean of the Yong Loo Lin School of Medicine. He is immediate past President of the Society of Infectious Diseases (Singapore) and Secretary-General of the Asia Pacific Society of Clinical Microbiology and Infection.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
The 17thICID Housing Office, MCI India, is pleased to offer a selection of official hotels. A complete list of available hotels is available.
All hotel locations can be found on the hotel map. Hotel room rates are in Indian Rupees (INR) and inclusive of all applicable taxes. Reservations are subject to availability.
To secure your hotel reservation full prepayment is required to secure your reservation. The hotel reservation deposit will be charged by MCI India. Credit card payment is necessary. After your housing request and credit card details have been received and processed, you will receive a confirmation including contact details as well as a receipt.
ISID and MCI India are not responsible for payments not sent as stated above. Do not combine registration fees and hotel deposits. Separate payments are required. Always indicate the delegate's name and reference number sent in the confirmation letter after the online reservation was made through the registration system.
If paying offline/bank transfer please ensure to provide full details of the payment made. Details of offline payments can be sent to firstname.lastname@example.org with the subject line Hotel Reservation Payment Details.
If corresponding with the Housing office, MCI Management India Pvt. Ltd., always indicate the delegate's name and reference number sent in the confirmation letter after the online reservation was made through the registration system.
All abstracts must be submitted electronically through the electronic abstract submission system. Click here to access the online submission system.
All abstracts must be received on or before November 1, 2015.
Abstracts received after this deadline will not be accepted for inclusion in the Congress.
All abstracts have a 350 word limit of text (not including presenter information and title).
Authors are advised to insure that their abstracts meet the criteria and guidelines below. All accepted abstracts will be published as is. Acceptance of the abstract in the program and assignment to a session are determined solely by the Program Committee based on a review of the abstract and its subject matter. Decisions of the Program Committee are final. Because of the logistics of assigning abstracts to sessions and the number of abstracts received, requests for particular types of presentations, sessions, days, or times will not be considered by the Program Committee.
Submitting authors are required to insure that all listed co-authors have reviewed the abstract, take responsibility for its content and agree with being listed as co-author.
All potential conflicts of interest for each co-author must be provided. Potential conflicts of interest include, but are not limited to, commercial interest in the research, and financial or in-kind support for the research, and financial or in-kind support for the research from entities with commerical interest in research.
The ICID Program Committee invites the submission of research abstracts of excellent quality in all areas related to infectious diseases. Authors with original research are encouraged to submit abstracts related to bacterial, fungal, parasitic, and viral infections, the pathogenesis of infectious diseases, antimicrobial agents, and related fields of investigation. All abstracts are reviewed by subcommittees of the 17th ICID Program Committee for the quality and originality of their research, scientific content, and presentation.
Abstracts may be accepted into one of three categories:
Oral presentation: The presenting author will be required to make a
7 minute Powerpoint presentation that concisely summarizes the research question, the methods used, the results and their significance. Abstracts accepted for oral presentation will be published as supplement to the International Journal of Infectious Diseases (IJID) and distributed to congress participants on site.
Poster presentation: The presenting author will be obliged to present the poster during the poster session to which it has been assigned. Abstracts accepted for poster presentation will be published as a supplement to the International Journal of Infectious Diseases (IJID) and distributed to congress participants on site.
International Scientific Exchange (ISE): Abstracts accepted for ISE will not be presented at the ICID. ISE accepted will be made available to congress participants electronically.
return to top
As part of the ongoing educational mission of the International Society for Infectious Diseases, the Program Committee encourages investigators from low–resource countries who have not previously submitted abstracts to international meetings to submit their original research. To assist such investigators the Program Committee has outlined the following guidelines for developing an abstract:
Abstracts must be based on original results that have not or will not be published or presented before the 17thICID begins on March 2, 2016.
It is recommended that abstracts follow a format similar to that used at other international meetings and in journals. An acceptable structure for an abstract includes:
Background: A statement of the hypothesis or research question.
Methods & Materials: An explanation of the study design and experimental method and materials used.
Results: A concise summary of the major findings of the experiment or study. Sufficient data must be provided to permit evaluation by the reviewers and public reading the abstracts. Statements such as "additional information to be presented at the meeting" are not acceptable.
Conclusion: Summary of the overall findings and the importance of the study.
-> DO NOT repeat these section headers in your abstract body! Do not format the complete abstract in bold or italic letters!
Abstracts that represent the presentation of single clinical cases of previously reported diseases, investigations of compounds that involve inadequate numbers of study subjects, or in vitro studies of nonrepresentative microbiologic strains, or abstracts that lack quantitative data will not be accepted. Authors are discouraged from submitting multiple abstracts from the same project. Each abstract will be judged on its own merits without reference to other submissions. Repetitive abstracts will be rejected.
All abstracts must be submitted in ENGLISH. The Program Committee recognizes that a number of abstracts will be from individuals for whom English is not their primary language. Though the focus of the review by the Program Committee will be the science, the Committee recommends that individuals who need assistance in writing in English have their abstracts reviewed before submission to the Congress.
Abstracts must be submitted through the electronic abstract submission system. Each abstract will be reviewed and scored by two members of the organizing committee for the quality and originality of the research, the scientific content and presentation. A notice of acceptance or rejection will be sent to the submitting authors only. It is the responsibility of the submitting author to notify other co-authors of the Committee's decision. Session assignments will be mailed by January 10, 2016 to the address given for correspondence. Once scheduled, presentations cannot be moved in the program. Authors are encouraged to submit their abstracts as early as possible.
By submitting an abstract the author(s) agree to transfer all copyrights to ISID and to allow publication of submitted information on the ISID web site, the International Journal of Infectious Diseases (IJID) or other Society related publications.
Instructions will be sent to the authors whose abstracts are accepted for oral or poster presentation. For each abstract accepted for presentation, at least one author must attend the Congress and present the contribution.
If the registration fee of the presenting author is not received by January 31, 2016 the abstract will not be published in the Final Program.
Authors who do not attend the session for which they have been scheduled will be ineligible to submit an abstract for the next ICID.
return to top
Abstracts can be easily submitted via the electronic abstract submisison system. From the ISID web site, you can fill out the abstract form directly and insert your computerized text. Detailed information and assistance on electronic submission are given when you visit this site.
Should you require further explanation, send an e-mail to email@example.com or call ISID at (617) 277–0551.
ISID concerns itself with education in infectious diseases, diagnosis of infections and clinical microbiology required for diagnosis, and different aspects of therapeutics concerning viral, bacterial, and parasitic infections. Sponsorship of symposia, research awards, educational grants, meet-the-expert sessions, and advertising in the conference materials and congress bags related to these subjects at the biennial ICID is invited.
Persons or companies interested in the exhibition and/or sponsorship opportunities should contact the Society as soon as possible at:
International Society for Infectious Diseases
Norman R. Stein
9 Babcock Street, Unit 3
Brookline, MA 02446
Phone: (617) 277-0551
Fax: (617) 278-9113
ISID Contact Information
Main address:9 Babcock Street, Unit 3, 02446, Brookline MA, USA
Tel: (1 617) 277 0551
Fax: (1 617) 278 9113
E-mail: info (at) isid.org